Malignant Neoplasms
|
0.310 |
AlteredExpression
|
group |
BEFREE |
Here, we investigated the transcriptional regulation of HA-1 gene expression in cancer.
|
19096014 |
2009 |
Malignant Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Moreover, we detected HA-1 promoter hypermethylation in primary cancers.
|
19096014 |
2009 |
Neoplasms
|
0.310 |
Biomarker
|
group |
CTD_human |
Our data suggest that promoter hypermethylation contributes to the HA-1 gene regulation in tumors.
|
19096014 |
2009 |
Neoplasms
|
0.310 |
Biomarker
|
group |
BEFREE |
Our data suggest that promoter hypermethylation contributes to the HA-1 gene regulation in tumors.
|
19096014 |
2009 |
Pre-Eclampsia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women.
|
26095815 |
2015 |
Benign Neoplasm
|
0.300 |
Biomarker
|
group |
CTD_human |
Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
|
19096014 |
2009 |
Graft-vs-Host Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
|
21243279 |
2010 |
Graft-vs-Host Disease
|
0.030 |
Biomarker
|
disease |
BEFREE |
Results of a previous study suggested that recipient mismatching for the minor histocompatibility antigen HA-1 is associated with acute graft-versus-host disease (GVHD) after allogeneic marrow transplantation.
|
10515896 |
1999 |
Graft-vs-Host Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
A mismatch of minor histocompatibility antigen HA-1 can cause GVHD in adult recipients of allogeneic bone marrow from HLA-identical donors.
|
8532022 |
1996 |
Acute GVH disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
|
10515896 |
1999 |
Acute GVH disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Recipient mismatching for the minor histocompatibility antigen HA-1 has been associated with acute graft-versus-host disease after allogeneic marrow transplantation.
|
9820595 |
1998 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
To investigate the function of HMHA1 and its encode protein HA-1 in melanoma.
|
28939173 |
2017 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Moreover, silencing HMHA1 not only significantly increased cell apoptosis but also suppressed cell migration and invasion.
|
28939173 |
2017 |
Chronic graft-versus-host disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
A univariate logistic regression model analysis showed that only acute graft-versus-host disease may be affected by recipient MiHAg-HA-1 disparity (p: 0.041, OR: 6.727), while chronic graft-versus-host disease correlates with both age and recipient/donor sex mismatch (p: 0.014, OR: 8.556 and p: 0.033, OR: 8.664, respectively).
|
21243279 |
2010 |
Primary malignant neoplasm
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Here, we investigated the transcriptional regulation of HA-1 gene expression in cancer.
|
19096014 |
2009 |
Primary Sjögren's syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
|
15593299 |
2005 |
Sjogren's Syndrome
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sjögren's syndrome.
|
15593299 |
2005 |
Influenza
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Direct polymerase chain reaction (PCR) amplifications of cDNA and subsequent nucleotide sequence analysis of part of the HA-1 gene of the original infecting influenza B strain and the nasal wash material from an infected volunteer were performed.
|
8227277 |
1993 |